Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times Kuwait.
Press releases published on September 11, 2025
Shoals Technologies Group Secures a New Patent for BLA Architecture, Reinforcing American Intellectual Property
GlobeNewswire
·
September 11, 2025
PORTLAND, Tenn., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (Shoals) (Nasdaq: SHLS), a global leader in electrical balance of system (EBOS) solutions for the energy transition market, announced today the issuance of its new U.S. …
VERSES® Expands Commercial Relationship with Major Global Investment Firm
GlobeNewswire
·
September 11, 2025
VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) ("VERSES'' or the "Company”), a cognitive computing company specializing in next-generation agentic software systems, today announced an additional …
FibroBiologics Announces Positive IND-Enabling Updates Demonstrating Potential of Fibroblast Spheroids in Chronic-Relapse Psoriasis Treatment
GlobeNewswire
·
September 11, 2025
HOUSTON, Sept. 11, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic …
Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium
GlobeNewswire
·
September 11, 2025
MORRISVILLE, N.C., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that the company will present four …
RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16th
GlobeNewswire
·
September 11, 2025
MOUNTAIN VIEW, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug- …
Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring
GlobeNewswire
·
September 11, 2025
Company expects early 2026 rollout in EEA; physician portal combines Lumee™ oxygen monitoring with NVIDIA NeMo to deliver AI-driven clinical workflows BERKELEY, Calif, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: …
Lexicon Pharmaceuticals to Present Additional Clinical Data on Pilavapadin at Three Upcoming Medical Meetings
GlobeNewswire
·
September 11, 2025
Presentations collectively highlight pilavapadin’s potential to improve pain management care for patients with diabetic peripheral neuropathic pain (DPNP) Breadth of the data across Phase 2 program to be discussed at Arrowhead’s 19th Annual Pain Summit THE …
Intercept Announces Voluntary Withdrawal of OCALIVA® for Primary Biliary Cholangitis (PBC) from the US Market; US Clinical Trials Involving Obeticholic Acid Placed on Clinical Hold
GlobeNewswire
·
September 11, 2025
MORRISTOWN, N.J., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a wholly owned biopharmaceutical subsidiary of Alfasigma S.p.A., today announced its decision to voluntarily withdraw OCALIVA® (obeticholic acid) from the US market for …
SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $23.6 Million in Gross Proceeds
GlobeNewswire
·
September 11, 2025
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
Cellectar Biosciences and ITM Enter Supply Agreement for GMP-Grade Actinium-225
GlobeNewswire
·
September 11, 2025
FLORHAM PARK, N.J. and GARCHING, Germany and MUNICH, Germany, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB, “Cellectar”), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for …
Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units
GlobeNewswire
·
September 11, 2025
CHICAGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly owned subsidiary, Sky Pharm SA, signed a …
authID and MajorKey Technologies Forge Strategic Alliance to Deliver High-Assurance Identity Verification for Microsoft Entra Customers
GlobeNewswire
·
September 11, 2025
New partnership brings seamless high-assurance biometric identity verification to Microsoft Entra Suite, combatting the rise in AI-driven fraud. DENVER, Sept. 11, 2025 (GLOBE NEWSWIRE) -- authID (Nasdaq: AUID), a leading provider of biometric identity …
NE2NE Launches PDFFlex to Easily and Accurately Extract Data from Complex PDF Files
GlobeNewswire
·
September 11, 2025
CLEVELAND, Sept. 11, 2025 (GLOBE NEWSWIRE) -- True to its mission as the world’s only fully agnostic data integration platform offering affordable, no-code solutions for small-to-midsized businesses, NE2NE today announced the launch of PDFFlex, an AI- …
Biodesix Announces One-for-Twenty Reverse Stock Split
GlobeNewswire
·
September 11, 2025
LOUISVILLE, Colo., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX) (“Biodesix” or the “Company”), a leader in personalized diagnostics, today announced a one-for-twenty reverse stock split (the “Reverse Stock Split”) of the Company’s …
ZenaTech Announces the Acquisition of Lescure Engineers Inc. Expanding Drone as a Service (DaaS) to California’s Precision Agriculture and Viticulture Markets
GlobeNewswire
·
September 11, 2025
VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), …
Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution
GlobeNewswire
·
September 11, 2025
BRIDGEWATER, N.J, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) approval of Amneal’s sodium oxybate oral solution 500 mg/mL Abbreviated New Drug …
Wearable Devices Announces Pricing of $4 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
·
September 11, 2025
Yokne’am Illit, Israel, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (the “Company” or “Wearable Devices”), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, …
CBSC Announces $375,000 Purchase Order and Launch of Recurring Revenue Program with Noventis Medical
GlobeNewswire
·
September 11, 2025
LAS VEGAS, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Cardiac Biotech Solutions, Inc. (OTCID: CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products, today announced the receipt of an …
BlockQuarry Corp. Introduces BLQCsmith Service Platform, Expanding Revenue Model with Advanced Mining Management Solutions
GlobeNewswire
·
September 11, 2025
HOUSTON, Sept. 11, 2025 (GLOBE NEWSWIRE) -- BlockQuarry Corp. (OTC: BLQC), a leading Texas-based energy and infrastructure company specializing in advanced mining solutions, today announces the development of BLQCsmith, a comprehensive service platform …
Global Mofy AI Launches New Website Domain to Strengthen Global AI Brand Identity
GlobeNewswire
·
September 11, 2025
BEIJING, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Global Mofy AI Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a generative AI-driven technology solutions provider engaged in virtual content production and the development of 3D digital assets for use …